Table 4.
Compound | Mechanism of Action | Clinical Trial Indication | Phase of Study |
---|---|---|---|
RMC-6236 | Pan-RAS inhibitor |
|
1 |
PF-07934040 | Pan-KRAS inhibitor |
|
1 |
YL-17231 | Pan-KRAS inhibitor |
|
1 |
Compound | Mechanism of Action | Clinical Trial Indication | Phase of Study |
---|---|---|---|
RMC-6236 | Pan-RAS inhibitor |
|
1 |
PF-07934040 | Pan-KRAS inhibitor |
|
1 |
YL-17231 | Pan-KRAS inhibitor |
|
1 |